Clinical Trial Update: Safety Study of Interferon Beta 1a to for Acute Stroke [Phase 1]

View source ↗

Summary

A Phase 1 safety study evaluating interferon beta-1a in acute stroke has completed, assessing safety and tolerability in participants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Interferon beta-1a (Interferon beta-1a)

Snippet

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Conditions: Cerebrovascular Accident | Phase 1 | Status: COMPLETED